Loading clinical trials...
Loading clinical trials...
Anticipated Patient and Caregiver Burden: Impact in People with Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a degenerative neurological disease that causes progressive motor disability and is life threatening within a few years. The severity of the disease, the progressive loss of autonomy that leads to dependence on family and caregivers, and the lack of effective treatment sometimes leads patients to a loss of hope and to dark thoughts. The prevalence of suicidal ideation is high, with more than one third of people with ALS experiencing it. The psychological suffering of patients is often associated with that of their caregivers. The evaluation of the patients' feeling of being a burden has rarely been addressed in previous studies in ALS on the notion of burden. In this work, the investigators wish to evaluate the patient's ideas of death by also taking into account the caregiver's burden and the patient's feeling of being a burden. They wish to better understand this difficult experience by refocusing the study on the patient himself, which has rarely been addressed in studies on ALS and the notion of burden. By working on the caregiver's burden, both from the caregiver's point of view and as perceived by the patient, the investigators hope to find avenues of intervention and define actions that could help patients and their families and improve the quality of life of the patient-caregiver couple.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Service Maladies neuromusculaires et SLA
Marseille, France
Start Date
June 22, 2023
Primary Completion Date
December 22, 2026
Completion Date
June 22, 2027
Last Updated
November 25, 2024
126
ESTIMATED participants
Psychological assessments
BEHAVIORAL
Annie Verschueren
CONTACT
Lead Sponsor
Assistance Publique Hopitaux De Marseille
NCT07322003
NCT05104710
NCT04715399
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions